dearth of actionable therapeutic targets. The majority of published studies investigating driver genes have focused primarily on genomic mutations which have led to novel study designs (basket trials) where patients…
distinct prefibrotic MPN without features of PV. Vainchenker (2005) discovered the JAK2V617F somatic mutation as the driver cause of ET, trilinear PV of erythrocytic, megakaryocytic and granulocytic myeloproliferation…
after treatment and after recurrence, has provided researchers with comprehensive collections of driver and passenger mutations that can be utilised to develop novel therapies. However, these sequencing techniques
hematopoiesis is a state in which substantial fraction of hematopoietic stem cells acquire mutations in specific driver genes and expand in the absence of an overt hematological malignancy. Recent clinical…
lung cancer, and skin cancer. We also developed two tests for sequencing somatic mutations in tumor driver genes. The first panel targets tumor driver genes using deoxyribonucleic acid (DNA) extracted ... invasive…
Targeting operable mutations in cancer driver genes has helped precision oncology make major strides. Recent research has started to look into the potential of tumor transcriptome to direct patient treatment
Cancer is caused by mutation(s) in driver gene(s), leading to the transformation of normal cell into malignant one, followed by rapid proliferation. Head and neck cancers (HNCs) comprise
cancer. Ã?Â?-Lapachone-exposed NQO1+ cancer cells are killed independent of oncogenic driver or passenger mutations, independent of p53 status, cell cycle status, and/or bak/bax loss
glucocerebrosidase gene (R120W, L444P+A456P+V460V) in the eyes using GMR-GAL4 driver. Three lines of mutated transgenic flies showed defective morphology in Drosophila eyes. Here, we present the data
lung lesions and distant metastatic foci, did not carry a high tumor mutation burden. Multiple potentially targetable driver genes were identified. Despite common involvement of transmembrane signaling pathways and…
sequencing (RNA-seq) can reveal structural and functional coding and noncoding mutational landscape. On the other hand, breakthrough genome studies applying NGS systems can evaluate genomic clonal evolution in time…
verification has to be performed by PCR to confirm the corresponding mutation at the genome level. Cancer driver genes APC, TP53 и KRAS are affected in 42-71% of cases ... rarely observed. It means that each tumor…
Large scale genetic/genomic studies have been conducted to uncover driver events of diseases such as germline or somatic mutations, gene fusion or translocations, methylation or other epigenetic changes, copy
models were also developed for the prediction of candidate driver genes of ovarian cancer along with a study of mutational landscape of ovarian cancer. It is envisaged that the work
deamination at WA-sites as the mutagenic driver in hepatocellular and possibly other related ADAR1-Hi cancers displaying biased mutation features at A:T base pairs
stomach cancer cells. Alteration analysis reveals that ATAD2 is a driver gene for stomach cancer, and 37 potential mutational sites (including the hot spot mutations at conserved ATPase domain
linked to genes that encode the proteins (connexins) used in gap junctional intercellular communication. Mutations in 50% of the 21 connexin gene family members result in conditions ranging from developmental ... GJIC…
addition to the JAK2V617 mutation several other mutations have been described. Recently chronic inflammation has been proposed as a trigger and driver of clonal evolution in MPNs. Herein ... bone marrow, thereby…
Somatic mutations in the JAK2, MPL and calreticulin (CALR) genes are the driver causes of clonal myeloproliferative neoplasms (MPN). Applying the WHO Clinical, Molecular and Pathologic (WHO-CMP) classification ... with…
cases are inherited in an autosomal dominant fashion and mutations in ALK and PHOX2B have been identified as the major drivers of this subset. Here, we report on efforts ... matched tumor-normal DNA pairs from 776 cases…
pathologies with JAK2 mutation for their diagnosis: strong (PV), moderately or weakly (ET, PMF). Conclusion: The clinical manifestations of these entities overlap, as do their genetic drivers, and they
Mutations are changes in the hereditary arrangement, and they are a fundamental driver of variety among creatures. These progressions happen at various levels, and they can have generally varying results
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.